Key facts
- RENAISSANCE TECHNOLOGIES LLC filed SCHEDULE 13G for Silo Pharma, Inc. Common Stock, par value $0.0001 per share.
- Disclosed ownership: 5.1%.
- Date of event: 04 Sep 2024.
RENAISSANCE TECHNOLOGIES LLC - 04 Sep 2024 SCHEDULE 13G Report for Silo Pharma, Inc. Common Stock, par value $0.0001 per share
- Filing Manager
- RENAISSANCE TECHNOLOGIES LLC
- Reporting Manager
- Renaissance Technologies LLC
- Shares outstanding
- 4,486,285 shares
- Disclosed Ownership
- 227,006 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Nov 2024, 14:50:31 UTC
- Date of event
- 04 Sep 2024
- Next filing
- 13 Feb 2025
- SEC
- View on sec.gov
Key filing fact
RENAISSANCE TECHNOLOGIES LLC disclosed 5.1% ownership in Silo Pharma, Inc. Common Stock, par value $0.0001 per share on 04 Sep 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2024, 14:50.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 5.1% | 227,006 | 227,006 | 0 | Brian Felczak | Chief Financial Officer | |
| Renaissance Technologies Holdings Corporation | 5.1% | 227,006 | 227,006 | 0 | Brian Felczak | Vice President |
CIK / CUSIP context first